96 related articles for article (PubMed ID: 8444654)
1. Synergy of cefotaxime and fosfomycin against penicillin-resistant pneumococci.
Barakett V; Lesage D; Delisle F; Burghoffer B; Richard G; Vergez P; Petit JC
J Antimicrob Chemother; 1993 Jan; 31(1):105-9. PubMed ID: 8444654
[TBL] [Abstract][Full Text] [Related]
2. [Bacteriostatic activity and killing curves of eight antibiotics against seven strains of penicillin G-resistant pneumococci].
Barakett V; Lesage D; Delisle F; Guidet B; Burghoffer B; Richard G; Offenstadt G; Vergez P; Petit JC
Pathol Biol (Paris); 1992 May; 40(5):483-91. PubMed ID: 1495831
[TBL] [Abstract][Full Text] [Related]
3. Effects of combination of benzylpenicillin and fosfomycin on penicillin-resistant Streptococcus pneumoniae.
Kikuchi K; Totsuka K; Shimizu K; Ishii T; Yoshida T; Orikasa Y
Microb Drug Resist; 1995; 1(2):185-9. PubMed ID: 9158754
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of cefepime and cefotaxime compared to six other agents against 350 penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Gomez-Lus R; Navarro C; Egido P; Aspiroz C; Goñi P; Vergara Y; Garcia C; Duran E; Castillo J; Rubio MC
J Chemother; 2000 Feb; 12(1):17-21. PubMed ID: 10768511
[TBL] [Abstract][Full Text] [Related]
5. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
Bajaksouzian S; Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Sep; 40(9):1973-6. PubMed ID: 8878565
[TBL] [Abstract][Full Text] [Related]
6. Comparative in-vitro activity of penicillin alone and combined with gentamicin against clinical isolates of Streptococcus pneumoniae with decreased susceptibility to penicillin.
Anadiotis L; Maskell JP; Sefton AM
Int J Antimicrob Agents; 2002 Mar; 19(3):173-81. PubMed ID: 11932138
[TBL] [Abstract][Full Text] [Related]
7. Killing kinetics of meropenem against penicillin-resistant pneumococci.
Barakett V; Lesage D; Delisle F; Richard G; Petit JC
J Antimicrob Chemother; 1996 Dec; 38(6):1085-9. PubMed ID: 9023658
[TBL] [Abstract][Full Text] [Related]
8. In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
Chavanet P; Beloeil H; Pechinot A; Duigou F; Buisson JC; Duong M; Neuwirth C; Kazmierczak A; Portier H
Antimicrob Agents Chemother; 1995 Aug; 39(8):1736-43. PubMed ID: 7486911
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to beta-lactam antibiotics.
Moore LJ; Gilbey AM; Dowson CG; Pridmore AC; Dower SK; Read RC
J Antimicrob Chemother; 2007 Jan; 59(1):35-42. PubMed ID: 17079241
[TBL] [Abstract][Full Text] [Related]
10. [Combination between fosfomycin and oxacillin or cefotaxime against methicillin-resistant Staphylococci and Enterococci].
Duez JM; Kohli E; Pechinot A; Tremeaux JC; Kazmierczak A
Pathol Biol (Paris); 1983 Jun; 31(6):515-8. PubMed ID: 6308543
[TBL] [Abstract][Full Text] [Related]
11. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200
[TBL] [Abstract][Full Text] [Related]
12. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
Rodríguez-Cerrato V; García P; Del Prado G; García E; Gracia M; Huelves L; Ponte C; López R; Soriano F
J Antimicrob Chemother; 2007 Nov; 60(5):1159-62. PubMed ID: 17827138
[TBL] [Abstract][Full Text] [Related]
13. Killing kinetics of RP 59500 and pristinamycin against penicillin-resistant pneumococci.
Barakett V; Lesage D; Delisle F; Richard G; Petit JC
Pathol Biol (Paris); 1997 May; 45(5):438-40. PubMed ID: 9296100
[TBL] [Abstract][Full Text] [Related]
14. In-vitro killing activity of combinations of beta-lactam agents with aminoglycosides against penicillin-resistant pneumococci.
Schlegel L; Sissia G; Fremaux A; Geslin P
J Antimicrob Chemother; 1997 Jan; 39(1):95-8. PubMed ID: 9044034
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
Marton A; Major P
Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
[TBL] [Abstract][Full Text] [Related]
16. [Sensitivity of penicillin-resistance pneumococci].
Cullmann W; Schlunegger H
Immun Infekt; 1993 Feb; 21(1):9-12. PubMed ID: 8330895
[TBL] [Abstract][Full Text] [Related]
17. Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae.
Bañón Arias R; García López M; Pinedo Sánchez A
J Chemother; 2001 Oct; 13(5):535-40. PubMed ID: 11760218
[TBL] [Abstract][Full Text] [Related]
18. Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro.
Lin E; Stanek RJ; Mufson MA
Antimicrob Agents Chemother; 2003 Mar; 47(3):1151-3. PubMed ID: 12604560
[TBL] [Abstract][Full Text] [Related]
19. Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test.
Jorgensen JH; Ferraro MJ; McElmeel ML; Spargo J; Swenson JM; Tenover FC
J Clin Microbiol; 1994 Jan; 32(1):159-63. PubMed ID: 8126173
[TBL] [Abstract][Full Text] [Related]
20. A time-kill study to evaluate the in-vitro activity of clofazimine in combination with cefotaxime against a penicillin- and cefotaxime-resistant strain of Streptococcus pneumoniae.
van Niekerk S; Huygens F; van Rensburg CE
J Antimicrob Chemother; 1997 Oct; 40(4):602-4. PubMed ID: 9372436
[No Abstract] [Full Text] [Related]
[Next] [New Search]
